IMvigor130 study: Final OS analysis of atezo + plt/gem vs placebo + plt/gem used to treat mUC
IMvigor130 study: Final OS analysis of atezo + plt/gem vs placebo + plt/gem used to treat mUC
Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer
JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for advanced urothelial carcinoma
Stereotactic body radiotherapy compared with surgery for localised prostate cancer
Changes in planned disease management after PET/CT in men with biochemically recurrent prostate cancer and low PSA levels
Abiraterone acetate/prednisone + apalutimide and ADT with post-op SRT may improve PFS and MFS after prostatectomy
Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous cell carcinoma
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer
Choosing Wisely in haemato oncology and medical oncology
Choosing Wisely in haemato-medical oncology
Choosing Wisely campaigns in Africa
Lessons learned from Choosing Wisely campaigns in Africa